HKD10.28
2.47% today
Hong Kong, Sep 16, 10:09 am CET
ISIN
HK1093012172
Symbol
1093
Index

CSPC Pharmaceutical Group Limited Target price 2025 - Analyst rating & recommendation

CSPC Pharmaceutical Group Limited Classifications & Recommendation:

Buy
75%
Hold
19%
Sell
6%

CSPC Pharmaceutical Group Limited Price Target

Target Price HKD11.22
Price HKD10.28
Potential
Number of Estimates 26
26 Analysts have issued a price target CSPC Pharmaceutical Group Limited 2026 . The average CSPC Pharmaceutical Group Limited target price is HKD11.22. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 32 analysts: 24 Analysts recommend CSPC Pharmaceutical Group Limited to buy, 6 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CSPC Pharmaceutical Group Limited stock has an average upside potential 2026 of . Most analysts recommend the CSPC Pharmaceutical Group Limited stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion HKD 31.70 32.70
7.76% 3.15%
EBITDA Margin 24.03% 27.43%
10.70% 14.15%
Net Margin 14.92% 18.87%
20.11% 26.48%

29 Analysts have issued a sales forecast CSPC Pharmaceutical Group Limited 2025 . The average CSPC Pharmaceutical Group Limited sales estimate is

HKD32.7b
Unlock
. This is
9.36% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD39.0b 8.04%
Unlock
, the lowest is
HKD28.9b 20.02%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 HKD31.7b 7.76%
2025
HKD32.7b 3.15%
Unlock
2026
HKD34.3b 4.75%
Unlock
2027
HKD35.7b 4.16%
Unlock
2028
HKD36.8b 3.23%
Unlock
2029
HKD39.4b 7.02%
Unlock
2030
HKD42.0b 6.65%
Unlock
2031
HKD44.5b 5.78%
Unlock
2032
HKD46.8b 5.29%
Unlock

26 CSPC Pharmaceutical Group Limited Analysts have issued a net profit forecast 2025. The average CSPC Pharmaceutical Group Limited net profit estimate is

HKD6.2b
Unlock
. This is
5.89% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD13.5b 131.30%
Unlock
, the lowest is
HKD4.3b 26.77%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 HKD4.7b 26.31%
2025
HKD6.2b 30.49%
Unlock
2026
HKD6.1b 0.38%
Unlock
2027
HKD6.4b 3.54%
Unlock
2028
HKD5.4b 15.66%
Unlock
2029
HKD6.0b 11.79%
Unlock
2030
HKD6.4b 6.44%
Unlock
2031
HKD6.6b 4.04%
Unlock
2032
HKD6.9b 3.88%
Unlock

Net Margin

2024 14.92% 20.11%
2025
18.87% 26.48%
Unlock
2026
17.95% 4.88%
Unlock
2027
17.84% 0.61%
Unlock
2028
14.58% 18.27%
Unlock
2029
15.23% 4.46%
Unlock
2030
15.19% 0.26%
Unlock
2031
14.95% 1.58%
Unlock
2032
14.75% 1.34%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share HKD 0.40 0.54
25.93% 35.00%
P/E 19.67
EV/Sales 3.33

26 Analysts have issued a CSPC Pharmaceutical Group Limited forecast for earnings per share. The average CSPC Pharmaceutical Group Limited EPS is

HKD0.54
Unlock
. This is
5.88% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
HKD1.17 129.41%
Unlock
, the lowest is
HKD0.37 27.45%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 HKD0.40 25.93%
2025
HKD0.54 35.00%
Unlock
2026
HKD0.53 1.85%
Unlock
2027
HKD0.55 3.77%
Unlock
2028
HKD0.47 14.55%
Unlock
2029
HKD0.52 10.64%
Unlock
2030
HKD0.55 5.77%
Unlock
2031
HKD0.58 5.45%
Unlock
2032
HKD0.60 3.45%
Unlock

P/E ratio

Current 20.67 144.20%
2025
19.67 4.82%
Unlock
2026
19.75 0.41%
Unlock
2027
19.07 3.44%
Unlock
2028
22.62 18.62%
Unlock
2029
20.23 10.57%
Unlock
2030
19.01 6.03%
Unlock
2031
18.27 3.89%
Unlock
2032
17.59 3.72%
Unlock

Based on analysts' sales estimates for 2025, the CSPC Pharmaceutical Group Limited stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.02 143.55%
2025
3.33 10.37%
Unlock
2026
3.18 4.53%
Unlock
2027
3.06 3.99%
Unlock
2028
2.96 3.14%
Unlock
2029
2.77 6.56%
Unlock
2030
2.59 6.24%
Unlock
2031
2.45 5.46%
Unlock
2032
2.33 5.02%
Unlock

P/S ratio

Current 3.30 110.18%
2025
3.64 10.33%
Unlock
2026
3.48 4.53%
Unlock
2027
3.34 3.99%
Unlock
2028
3.23 3.13%
Unlock
2029
3.02 6.56%
Unlock
2030
2.83 6.24%
Unlock
2031
2.68 5.46%
Unlock
2032
2.54 5.02%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today